first extended service corporation
Monday, January 14, 2013
BRIEF-Neuralstem jumps in premarket after FDA OK's spinal cord injury trial
NEW YORK, Jan 14 (Reuters) - Neuralstem Inc :
* Jumps 15.3 percent to $1.43 in premarket after FDA ok's
spinal cord injury trial
car insurance assessor
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment